English, Article edition: Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease Dyfrig A. Hughes; Keith Bodger; Peter Bytzer; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/94978
Physical Description
  • article
Language
  • English

Edition details

Title
  • Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease
Author
  • Dyfrig A. Hughes
  • Keith Bodger
  • Peter Bytzer
  • Dirk de Herdt
  • Dominique Dubois
Physical Description
  • article
Notes
  • Aim: To evaluate the costs and effectiveness of on-demand maintenance therapy with oral esomeprazole, lansoprazole, omeprazole, pantoprazole or rabeprazole in patients with endoscopy-confirmed non-erosive reflux disease (NERD) in the UK. Methods: A probabilistic model was developed to compare the costs and effectiveness of five proton pump inhibitors (PPIs) in endoscopy-negative, symptomatic NERD patients who had complete resolution of heartburn symptoms following 4 weeks of open-label acute PPI treatment. The total annual expected costs (_, 2003 values) and utilities gained per patient were measured over a 1-year horizon from the perspective of the UK NHS. Model uncertainty was addressed by sensitivity analyses. Results: The base-case annual median costs and utilities gained with on-demand PPI therapy were: _123 and 0.89 for rabeprazole 10mg; _176 and 0.90 for pantoprazole 20mg; _190 and 0.89 for esomeprazole 20mg; _195 and 0.91 for lansoprazole 15mg; _201 and 0.90 for omeprazole 20mg; and _210 and 0.91 for omeprazole 10mg. Differences in costs, but not in outcomes, were statistically significant. The results were robust to sensitivity analyses. Conclusions: In this analysis, on-demand use of rabeprazole for the management of NERD incurred the least cost in comparison with the other PPIs evaluated. Utility gains were comparable for all on-demand PPIs. The place of on-demand PPIs in therapy, however, requires further evaluation.
  • Cost-utility, Esomeprazole, Gastro-oesophageal-reflux, Lansoprazole, Omeprazole, Pantoprazole, Rabeprazole
  • RePEc:wkh:phecon:v:23:y:2005:i:10:p:1031-1041
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment